CASH AND EQUIVALENTS AND MARKETABLE SECURITIES

The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents.

Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value.” The Company's investment in GCS Holdings is included in "Other Assets" as available-for-sale and at fair value. The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations.

The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three months ended April 1, 2017 and the year ended December 31, 2016.

Investments in available-for-sale marketable debt securities are as follows at April 1, 2017 and December 31, 2016:



	Amortized Cost				Unrealized Gains				Unrealized Losses						Fair Value
	2017		2016		2017		2016		2017			2016			2017		2016
U.S. government and agency backed securities	$	35,116,536	$	36,343,817	$	—	$	—	$	(201,268	)	$	(252,556	)	$	34,915,268	$	36,091,261
Corporate debt and certificates of deposit	14,475,561		25,323,428		—		—		(33,326		)	(39,288		)	14,442,235		25,284,140
Total	$	49,592,097	$	61,667,245	$	—	$	—	$	(234,594	)	$	(291,844	)	$	49,357,503	$	61,375,401

The contractual maturity of the Company’s marketable debt securities is as follows at April 1, 2017:



	Less than One year		One to Five years		Greater than Five years		Total
U.S. government and agency backed securities	$	15,495,380	$	15,501,588	$	3,918,300	$	34,915,268
Corporate debt and certificates of deposit	13,484,735		957,500		—		14,442,235
Total	$	28,980,115	$	16,459,088	$	3,918,300	$	49,357,503

The Company conducts a review of its marketable debt securities on a quarterly basis for the presence of other-than-temporary impairment (OTTI). The Company assesses whether OTTI is present when the fair value of a debt security is less than its amortized cost basis at the balance sheet date. Under these circumstances OTTI is considered to have occurred (1) if the Company intends to sell the security before recovery of its amortized cost basis; (2) if it is “more likely than not” the Company will be required to sell the security before recovery of its amortized cost basis; or (3) the present value of expected cash flows is not sufficient to recover the entire amortized cost basis.

The Company further estimates the amount of OTTI resulting from a decline in the creditworthiness of the issuer (credit-related OTTI) and the amount of non credit-related OTTI. Non credit-related OTTI can be caused by such factors as market illiquidity. Credit-related OTTI is recognized in earnings while non credit-related OTTI on securities not expected to be sold is recognized in other comprehensive income (loss). The Company did not record an OTTI for the three months ended April 1, 2017 and March 26, 2016.